From our analysis of acyl carnitines in TRAMPC1 and MyC-CaP cells, it is reasonable to speculate that fatty acid-carnitine derivatives produced by the tumor cells could be supporting the fat oxidation phenotype of the tolerogenic TME, supporting cancer growth. The gene discussed is MYC; the disease is cancer.